A Randomized Cohort Study: Is It Worth the Time to Receive Antiandrogenic Pretreatment Before Ovulation Induction for Women With Polycystic Ovary Syndrome?

    February 2022 in “ Frontiers in Endocrinology ”
    Zhiyan Chen, Jichun Tan, Huichun Wang … Qi Yu
    Studysummary This study found that antiandrogenic pretreatment with combined oral contraceptives did not improve ovulation and pregnancy outcomes compared to direct letrozole induction in women with PCOS.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on frontiersin.org →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Polycystic Ovarian Syndrome: Correlation Between Hyperandrogenism, Insulin Resistance, and Obesity Clinica Chimica Acta · 2019
    2. Polycystic Ovary Syndrome: Comprehensive Overview Obstetrics & Gynecology · 2018
    3. Androgen Excess: Investigations and Management Best Practice & Research in Clinical Obstetrics & Gynaecology · 2016
    4. The Androgen Excess and PCOS Society Criteria for the Polycystic Ovary Syndrome: The Complete Task Force Report Fertility and Sterility · 2008